Ipr1遺伝子は,結核に対する先天的な免疫を媒介する
Hui Pan1, Bo-Shiun Yan, Mauricio Rojas
1Department of Immunology and Infectious Diseases, Harvard School of Public Health, 667 Huntington Avenue, Boston, Massachusetts 02115, USA.
Nature
|April 9, 2005
まとめ
新たに特定された遺伝子である細胞内病原体耐性1 (Ipr1) は,結核に対する宿主耐性を高めます. マクロファージにおけるその発現は病原体の増殖を制限し,アポトーシスを促進し,Mycobacterium tuberculosisに対する先天的な免疫に関する新しい洞察を提供します.
科学分野:
- 遺伝学 遺伝学とは
- 免疫学 免疫学とは
- 微生物学 微生物学とは
背景:
- 結核 (TB) は,世界中で何百万人もの人に影響していますが,感染した人のほんの一部だけが病気を発症し,宿主の遺伝要因が感受性に影響することを示唆しています.
- Mycobacterium tuberculosisに対する宿主耐性の遺伝的基礎は,大部分が特徴づけられていないままである.
- マウスの染色体1の以前に特定された遺伝的場所,sst1は,結核に対する超感受性に関連していた.
研究 の 目的:
- 結核に対する先天的免疫を媒介するsst1の役割を調査する.
- ホストの耐性に対するsst1ロカス内の候補遺伝子を識別する.
- ホストの防御機構における識別された遺伝子の機能を明らかにする.
主な方法:
- sst1ロカスで異なった先天性マウス株は,先天的免疫を研究するために使用されました.
- 遺伝子発現分析は,感受性および耐性マウス株のマクロファージで行われました.
- 機能的研究は,病原体の成長と細胞死に対するその影響を評価するために,感受性の高いマクロファージに候補遺伝子トランスゲンを発現することを含む.
主要な成果:
- sst1ローカスは,マウスモデルにおける先天的免疫を媒介することが示された.
- 候補遺伝子である細胞内病原体耐性1 (Ipr1) は,sst1の場所内に特定されました.
- Ipr1発現は,耐性マクロファージでは検出されたが,感受性マクロファージでは検出されなかった.
- 敏感なマクロファージにおけるIpr1の発現は,Mycobacterium tuberculosisとListeria monocytogenesの複製を制限しました.
- Ipr1の発現は,感染したマクロファージの細胞死亡をネクロスからアポトーシスにシフトさせた.
結論:
- Ipr1遺伝子は,先天的免疫と細胞内細菌の病原体に対する宿主耐性において重要な役割を果たします.
- Ipr1は,細胞死経路を含む先天的な免疫反応と病原体由来信号を統合することができる.
- Ipr1の機能を理解することで,結核などの感染症に対する新たな治療目標が明らかになる可能性があります.
関連する概念動画
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:31Regulation of the Unfolded Protein Response
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
01:32Chromatin Modification in iPS Cells
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...